It was further found that systemic estrogen supplementation or local ERβ agonism within the LHb could improve anxiety-like behavior and reverse estrogen-deficiency-induced decreases in monoamine neurotransmitter levels of the DRN and VTA. The gene discussed is ESR2; the disease is Anxiety.